Clinical Trial Results: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]

View source ↗

Summary

Phase 1 study results for LY3502970 in Chinese participants with overweight or obesity and weight-related comorbidities have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3502970

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2026-07-17